IRIS
CATTANEO, DARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.327
SA - Sud America 2.100
NA - Nord America 900
EU - Europa 266
AF - Africa 117
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 6.714
Salva come PNG Salva come JPEG
Nazione #
BR - Brasile 1.655
SG - Singapore 1.508
VN - Vietnam 1.162
US - Stati Uniti d'America 787
CN - Cina 252
AR - Argentina 200
ID - Indonesia 95
EC - Ecuador 85
BD - Bangladesh 74
IT - Italia 67
MX - Messico 59
HK - Hong Kong 48
ZA - Sudafrica 46
CO - Colombia 44
RU - Federazione Russa 42
PY - Paraguay 40
IQ - Iraq 37
IN - India 33
CL - Cile 28
UA - Ucraina 24
CA - Canada 21
GB - Regno Unito 20
VE - Venezuela 19
DE - Germania 16
PE - Perù 15
FR - Francia 14
MA - Marocco 14
PK - Pakistan 14
EG - Egitto 12
UZ - Uzbekistan 12
DZ - Algeria 10
PL - Polonia 10
KE - Kenya 9
MY - Malesia 9
SA - Arabia Saudita 9
UY - Uruguay 9
DO - Repubblica Dominicana 8
ES - Italia 8
AL - Albania 7
IE - Irlanda 7
JM - Giamaica 7
PH - Filippine 7
SN - Senegal 7
TR - Turchia 7
AZ - Azerbaigian 6
JP - Giappone 6
NP - Nepal 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
FI - Finlandia 5
KZ - Kazakistan 5
SE - Svezia 5
SI - Slovenia 5
BO - Bolivia 4
CZ - Repubblica Ceca 4
IL - Israele 4
JO - Giordania 4
LB - Libano 4
TT - Trinidad e Tobago 4
AT - Austria 3
BG - Bulgaria 3
CR - Costa Rica 3
GT - Guatemala 3
KW - Kuwait 3
NL - Olanda 3
OM - Oman 3
PA - Panama 3
AM - Armenia 2
AU - Australia 2
BE - Belgio 2
BW - Botswana 2
BY - Bielorussia 2
CH - Svizzera 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
NG - Nigeria 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CD - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GY - Guiana 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
KY - Cayman, isole 1
LT - Lituania 1
Totale 6.705
Salva come PNG Salva come JPEG
Città #
Ho Chi Minh City 431
Ashburn 294
Singapore 292
Hanoi 240
Dallas 173
San Jose 143
São Paulo 125
Beijing 86
Rio de Janeiro 58
Da Nang 52
Hong Kong 44
Haiphong 39
Biên Hòa 38
Hải Dương 34
Curitiba 33
Assago 30
Brasília 29
Guayaquil 28
Porto Alegre 27
Thái Bình 26
Belo Horizonte 25
Quito 23
Campinas 21
Ninh Bình 21
Salvador 21
Johannesburg 20
Guarulhos 19
Ribeirão Preto 19
Buenos Aires 18
Can Tho 17
Fortaleza 17
New York 16
Santo André 15
Sorocaba 15
Bắc Giang 14
Jakarta 14
Los Angeles 14
Manaus 14
Mexico City 14
Thái Nguyên 14
Bogotá 13
Phủ Lý 12
Resistencia 12
Baghdad 11
Cape Town 11
Goiânia 11
Santiago 11
São Gonçalo 11
Viamão 11
Wilmington 11
Asunción 10
Belém 10
Caxias do Sul 10
Ha Long 10
Lấp Vò 10
Orem 10
Santa Clara 10
Tashkent 10
Cotia 9
Dhaka 9
Franca 9
Medellín 9
Piracicaba 9
Caracas 8
Guarujá 8
Hortolândia 8
Juiz de Fora 8
Mauá 8
Milan 8
Montreal 8
Pelotas 8
Quảng Ngãi 8
Sumaré 8
Warsaw 8
Bandung 7
Cairo 7
Carapicuíba 7
Dakar 7
Dublin 7
Huế 7
Lima 7
Montes Claros 7
Nairobi 7
Osasco 7
Suzano 7
São Bernardo do Campo 7
São José do Rio Preto 7
Volta Redonda 7
Aracaju 6
Barra Mansa 6
Bắc Ninh 6
Chennai 6
Colombo 6
Denpasar 6
Frankfurt am Main 6
Indaiatuba 6
Long An 6
Macapá 6
Montevideo 6
Quận Một 6
Totale 3.070
Salva come PNG Salva come JPEG
Nome #
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma. 78
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial 50
"CATCH" Study: Correct Antibiotic Therapy in Continuous Hemofiltration in the Critically Ill in Continuous Renal Replacement Therapy: A Prospective Observational Study 42
Are non-serious adverse reactions to psychiatric drugs really non-serious ? 38
Acute kidney injury in a preterm infant homozygous for the C3435T polymorphism in the ABCB1 gene given oral morphine 37
Pharmacogenomics of immunosuppressive agents: perspective for individualized therapy 36
C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation 35
ABCC4 single-nucleotide polymorphisms as markers of tenofovir disoproxil fumarate-induced kidney impairment 35
Neonatal Outcomes of Newborns Exposed to SSRI during Pregancy: a Pharmacokinetic and Pharmacogenetic Analysis 34
A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy 34
Pharmacokinetics help optimizing mycophenolate mofetil dosing in kidney transplant patients 33
Application Of Quality By Design Approach To Bioanalysis: Development Of A Method For Elvitegravir Quantification In Human Plasma 33
Antibiotic Therapy Strategies for Treating Gram- Negative Severe Infections in the Critically Ill: A Narrative Review. 32
Simultaneous determination of everolimus and cyclosporine concentrations by HPLC with ultraviolet detection 32
Practices of therapeutic drug monitoring in tuberculosis - an international survey 32
ACE inhibitors and ribavirin-associated cough: a common undefined predisposing factor? 32
Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects 32
Preventing COVID-19 in assisted living facilities: An impossible task pending vaccination roll out 31
A three-in-one, long-acting, nanosuspension reformulation of off-patent antiretrovirals for low-income and middle-income countries 31
Appropriateness of loading dose and TDM in patients treated with teicoplanin: a single-centre observational retrospective cohort study comparing single-daily and thrice-weekly regimens 31
Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV 31
Population Pharmacokinetics of Mycophenolic Acid A Comparison between Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil in Renal Transplant Recipients 31
Lights and shadows of the actual European guidelines on bioanalytical method validation : the case of raltegravir 31
Loss of Control of HIV Viremia With OTC Weight-Loss Drugs: A Call for Caution? 30
Fast clearance of anti-TNFα agents unrelated to antidrug antibodies: a case report 30
Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans 30
Therapeutic drug monitoring of sirolimus: Effect of concomitant immunosuppressive therapy and optimization of drug dosing 30
Liver Injury After Dietary Supplements in Patients Living With HIV: A Call to Action 30
Dosing of dolutegravir in TB/HIV co-infected patients on rifampicin: twice is (always) better than once 29
Aldosterone and progression of kidney disease 29
Potential association between rosuvastatin use and high atazanavir trough concentrations in ritonavir-treated HIV-infected patients 29
Effect of combining ACE inhibitor and statin in severe experimental nephropathy 29
Therapeutic Drug Monitoring of Dalbavancin in Real Life: A Two-Year Experience 29
Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure 29
A Comparison of Tenofovir Predose Concentrations in Generic Pre-exposure Prophylaxis Formulations: A Short Communication 29
Pharmacokinetics of mycophenolate sodium and comparison with the mofetil transplant recipients formulation in stable kidney 29
Practices of therapeutic drug monitoring in tuberculosis: an international survey. 29
Analytical performance specifications for measurement uncertainty in therapeutic monitoring of immunosuppressive drugs 28
Therapeutic Drug Monitoring of Antibiotics in the Elderly: A Narrative Review 28
Drug-Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients 28
Increased levetiracetam clearance and breakthrough seizure in a pregnant patient successfully handled by intensive therapeutic drug monitoring 28
Limited Sampling Strategies for the Estimation of Sirolimus Daily Exposure in Kidney Transplant Recipients on a Calcineurin Inhibitor-Free Regimen 28
Psychoactive drugs and HIV: are we sure to treat our patients adequately? 28
Proactive therapeutic monitoring of dalbavancin concentrations in the long-term management of chronic osteoarticular/periprosthetic joint infections 28
[Functional loss of the transplanted kidney: immunological and non-immunological factors]. FT La perdita di funzione del rene trapiantato: fattori immunologici e non-immunologici 28
Two-hour blood cyclosporine level does not necessarily predict drug exposure and graft function outcome in stable kidney transplant recipients 28
Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts 28
Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Mycobacterial Infection: A 1-Year Experience of a Multidisciplinary Outpatient Clinic 28
Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy 28
Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans 27
The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions 27
When the absence of an interaction can become clinically relevant 27
Delayed graft function in kidney transplantation 27
Multidrug-resistant HIV viral rebound during early syphilis: a case report 27
Application of Quality by Design Approach to Bioanalysis: Development of a Method for Elvitegravir Quantification in Human Plasma 27
Comparison of different cyclosporine immunoassays to monitor C-0 and C-2 blood levels from kidney transplant recipients: Not simply overestimation 27
Pharmacogenetics of immunosuppressants and clinical outcome 27
In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: Insights from the MYSS Trial 27
Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: Evidence from a safety study with pilot efficacy measures in adult dystrophic patients 27
Drug-Drug Interactions Between Antiretrovirals and Carbamazepine/Oxcarbazepine: A Real-Life Investigation 27
Optimizing Antibiotic Therapy for Intravenous Drug Users: A Narrative Review Unraveling Pharmacokinetics/Pharmacodynamics Challenges 27
Limited Sampling Strategies for the Estimation of Raltegravir Daily Exposure in HIV-Infected Patients 26
Development and Validation of a Chromatographic Ultraviolet Method for the Quantification of Isavuconazole in Human Plasma Samples 26
Effects of rosuvastatin on glomerular capillary size-selectivity function in rats with renal mass ablation 26
Assessment of sirolimus concentrations in whole blood by high-performance liquid chromatography with ultraviolet detection 26
Determination of atazanavir in human plasma by high-performance liquid chromatography with UV detection 26
Proactive therapeutic monitoring of dalbavancin concentrations in the long-term management of chronic osteoarticular/periprosthetic joint infections 26
Effects of ursodeoxycholic acid on rilpivirine plasma trough concentrations: a case report 26
Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics 26
Duloxetine in elderly major depression disorder: effectiveness and drug plasma level evaluation 26
Transplacental passage of ritonavir-boosted darunavir in two pregnant women 26
Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury 26
Comparison of the in vivo pharmacokinetics and in vitro dissolution of raltegravir in HIV patients receiving the drug by swallowing or by chewing 26
Elvitegravir/cobicistat-associated toxic optical neuropathy in an HIV-infected patient: a call for caution? 26
Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose? 26
Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies 26
Can We Rely on AGNP Therapeutic Targets Also For LAI Antipsychotics? 26
Why Product Information Should not be Set in Stone: Lessons from a Decade of Linezolid Therapeutic Drug Monitoring: An Opinion Paper 26
Population pharmacokinetics and target attainment analysis of linezolid in multidrug- resistant tuberculosis patients 26
Therapeutic use of HMG-CoA reductase inhibitors: current practice and future perspectives 26
Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies : evidence from a safety study with pilot efficacy measures in adult dystrophic patients 25
From pharmacokinetics to pharmacogenomics: A new approach to tailor immunosuppressive therapy 25
Chemotherapy, targeted therapy and immunotherapy: Which drugs can be safely used in the solid organ transplant recipients? 25
Linezolid-related haematological toxicity in a peritoneal dialysis patient: the role of therapeutic drug monitoring 25
Paliperidone LAI and Aripiprazole LAI Plasma Level Monitoring in the Prophylaxis of Bipolar Disorder Type I with Manic Predominance 25
Case of Suboptimal Linezolid Exposure: Is There a Role for Pharmacogenetics? 25
Doravirine/tenofovir disoproxyl fumarate/lamivudine-induced alopecia: A case report 25
Development and validation of a chromatographic ultraviolet method for the simultaneous quantification of dolutegravir and rilpivirine in human plasma 25
Ameliorating Hypertension and Insulin Resistance in Subjects at Increased Cardiovascular Risk Effects of Acetyl-L-Carnitine Therapy 25
Can We Rely on AGNP Therapeutic Targets also for LAI Antipsychotics? 25
Second generation antipsychotics in 'real-life' paediatric patients : adverse drug reactions and clinical outcomes of drug switch 25
Pharmacovigilance knowledge in family paediatricians. A survey study in Italy 25
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies : evidence from Phase I studies in healthy volunteers 25
Optimizing immunosuppressive drug dosing in pediatric renal transplantation 25
Therapeutic drug management of linezolid : a missed opportunity for clinicians? 25
Therapeutic drug monitoring and pharmacogenetics of antipsychotics and antidepressants in real life settings: A 5-year single centre experience 25
Therapeutic drug monitoring and pharmacogenetics of antipsychotics and antidepressants in real life settings: A 5-year single centre experience 25
Cyclosporine formulation and Kaposi's sarcoma after renal transplantation 25
Influence of co-medication with sirolimus or cyclosporine on mycophenolic acid pharmacokinetics in kidney transplantation. 25
Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones 24
Totale 2.895
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.393
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.393
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 2 0 2
2021/202213 0 0 0 2 0 0 1 1 1 1 3 4
2022/202319 5 0 3 3 1 1 0 1 1 2 2 0
2023/202414 2 2 3 0 0 0 3 1 0 0 1 2
2024/202517 1 0 0 0 0 3 0 1 2 7 0 3
2025/20266.934 315 486 1.066 2.378 534 184 803 522 404 242 0 0
Totale 7.022